Currently, one can only speculate that anti-GnRH toxicity may be dependent on antibody heterogeneity, as described, for example, in atherosclerosis [25] or other factors, in addition to auto antibodies, are necessary to be present to amplify or execute neurodegenerative effects. The gene discussed is GNRH1; the disease is atherosclerosis.